Rallybio (RLYB) Accumulated Expenses (2020 - 2026)

Rallybio has reported Accumulated Expenses for 7 years, with the latest figure at $3.1 million in Q1 2026.

• Quarterly Accumulated Expenses rose 21.8% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 21.8% YoY) and the FY2025 annual result came in at $3.8 million, down 23.6% from the prior year.
• Accumulated Expenses slipped to $3.1 million in Q1 2026 per RLYB's latest filing, from $3.8 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $9.5 million in Q2 2024 and troughed at $1.0 million in Q1 2022.
• A 5-year average of $5.6 million and a median of $5.0 million in 2024 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2023 and 2025: Accumulated Expenses surged 458.1% in 2023, then sank 72.89% in 2025.
• Over 5 years, Accumulated Expenses stood at $9.4 million in 2022, then decreased by 14.62% to $8.1 million in 2023, then sank by 38.5% to $5.0 million in 2024, then decreased by 23.6% to $3.8 million in 2025, then declined by 18.2% to $3.1 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $3.1 million, $3.8 million, and $3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.